Whalegun
Home

Mark Rothera, President and CEO: Viracta Therapeutics VIRX Buy · Filed 23/12/04

Trade details

Type
Insider buy
Amount
$23,473.94
Shares · price
47,906 sh · $0.49 a share
Held after
100,000 sh
Stock
Viracta Therapeutics VIRX
Person
Mark RotheraPresident and CEO
Trade date
23/12/01
Filed
23/12/04
Days to filing
3 days

Holdings up 92.0%

Insiders buying this week
1 insiders
Holding change
+92.0%

Viracta Therapeutics trades, last 26 weeks

What else happened in Viracta Therapeutics around then

Filed or reported within 30 days of the trade day · 23/11/01~23/12/31

Mark Rothera's recent trades

  • Mark Rothera

    BuyViracta Therapeutics

    $25.5K

    Filed 23/12/04

Mark Rothera, CEO — bought $23.5K of Viracta Therapeutics VIRX · 47,906 sh @ $0.49 | Whalegun